SALARIUS PHARMACEUTICALS INC (SLRX)
US79400X3052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.90M | 12.11M | 29.21M | 11.12M | 3.74M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 0.00 | 1.61M | 0.00 | 3.86M | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 619.76K | 800.00K | 950.00K | 820.00K | 960.00K | |||
| Total Current Assets | 6.52M | 14.52M | 30.16M | 15.80M | 4.69M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 10.00K | 20.00K | 30.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | 0.00 | 8.87M | 8.87M | 8.87M | |||
| Other Non-Current Assets | 66.85K | 130.00K | 190.00K | 250.00K | 310.00K | |||
| Total Non-Current Assets | 66.85K | 130.00K | 10.67M | 9.13M | 9.20M | |||
| TOTAL ASSETS | 6.59M | 14.65M | 40.83M | 24.93M | 13.89M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 289.64K | 0.00 | 0.00 | 480.00K | 500.00K | |||
| Accrued Expenses | 406.75K | 1.41M | 550.00K | 380.00K | 160.00K | |||
| Accounts Payable | 602.85K | 2.86M | 1.54M | 1.85M | 1.79M | |||
| Other Current Liabilities | N/A | N/A | 10.00K | 60.00K | 860.00K | |||
| Total Current Liabilities | 1.30M | 4.27M | 2.11M | 2.77M | 3.31M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 1.30M | 4.27M | 2.11M | 2.77M | 3.31M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -76.35M | -63.81M | -32.20M | -19.43M | -12.08M | |||
| Additional Paid In Capital | 81.63M | 74.19M | 70.92M | 41.59M | 22.66M | |||
| Common Shares | 390.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 3.94M | 2.26M | 1.81M | 950.00K | 180.00K | |||
| Tangible Book Value per Share | 1.34 | 4.59 | 16.49 | 13.99 | 9.50 | |||
| Total Shareholders' Equity | 5.29M | 10.38M | 38.72M | 22.16M | 10.58M | |||
| TOTAL LIABILITIES AND EQUITY | 6.59M | 14.65M | 40.83M | 24.93M | 13.89M | |||
| Statistics | ||||||||
| Current Ratio | 5.02 | 3.40 | 14.29 | 5.70 | 1.42 | |||
| Return On Assets (ROA) | -190.43% | -215.77% | -31.28% | -31.09% | -49.96% | |||
| Return On Equity (ROE) | -237.22% | -304.53% | -32.98% | -34.97% | -65.60% | |||
All data in USD